ACADIA Pharmaceuticals, Inc. (ACAD)
26.94
-0.48
(-1.77%)
USD |
NASDAQ |
Jan 08, 16:00
26.94
0.00 (0.00%)
After-Hours: 19:51
ACADIA Pharmaceuticals Research and Development Expense (Annual): 303.25M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Aldeyra Therapeutics, Inc. | 48.22M |
| Vanda Pharmaceuticals, Inc. | 74.43M |
| ADMA Biologics, Inc. | 1.813M |
| Amicus Therapeutics, Inc. | 109.36M |
| ANI Pharmaceuticals, Inc. | 44.58M |